You are viewing a preview of this job. Log in or register to view more details about this job.

CDC Economic Evaluation Training Fellowship

*Applications will be reviewed on a rolling-basis.

A fellowship opportunity is currently available with the Global Immunization Division (GID) within the Center for Global Health (CGH) at the Centers for Disease Control and Prevention (CDC) located in Atlanta, Georgia.

The Centers for Disease Control and Prevention (CDC) is one of the major operation components of the Department of Health and Human Services. CDC works to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.

The Global Immunization Division (GID) is responsible for coordinating the agency’s global immunization strategies and engagement with external partners working in global immunization such as Gavi, the Vaccine Alliance. GID staff conduct research and evaluation, provide technical assistance, and support implementation of immunization programs at country, regional, and global levels. GID staff come from a range of backgrounds, including medicine, epidemiology, communications, informatics, statistics, economics, and public policy. About 75% of staff are based in Atlanta and 25% of staff are based overseas. Further information about CDC’s global immunization work is available at: https://www.cdc.gov/globalhealth/immunization/default.html

GID's Economics Unit is seeking a qualified and motivated candidate for an Economic Evaluation Training Fellowship focused on developing skills and experience in conducting economic evaluation of immunization program interventions in low- and middle-income countries. The fellow will participate under the mentorship of GID economists to develop skills and experience in designing project protocols and data collection tools; cleaning and analyzing data collected in the field; and developing presentations, reports, and manuscripts to disseminate results for several economic evaluation projects across different countries. Anticipated economic evaluation projects address different vaccine-preventable diseases within GID’s scope (e.g., polio, measles and rubella, Hepatitis B, COVID-19), with a focus on GID’s Tier 1 countries (Afghanistan, Democratic Republic of Congo, Ethiopia, India, Indonesia, Nigeria, Pakistan, Philippines).

Learning objectives include:

  • Improve skills in economic evaluation design, data collection tool development, and data management and analysis methods
  • Build professional networks and applied experience through collaboration with CDC staff and international and country partners in development and implementation of global immunization economic evaluations
  • Increase knowledge and experience of how economic evaluation evidence can contribute to country and global immunization program decision making
  • Gain experience in development of economic evaluation dissemination products (e.g., presentations, reports, journal manuscripts)

Anticipated Appointment Start Date: 2021; start date is flexible

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and CDC. The initial appointment can be up to one year, but may be renewed upon recommendation of CDC contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at CDC in the Atlanta, Georgia, area. Participants do not become employees of CDC, DOE or the program administrator, and there are no employment-related benefits.

If you have questions, send an email to ORISE.CDC.CGH@orau.org. Please include the reference code (CDC-CGH-2021-0201) for this opportunity in your email.